Abstract:Background Individuals with Parkinson's Disease (PD) commonly have reduced exercise capacity, which impacts autonomy and quality of life. The 6-minute walk test (6MWT) has adequate measurement properties to assess exercise capacity in this population. However, these individuals have a reduced fatigue threshold, which may make it difficult to apply prolonged exercise tests. Two-minute walk test (2MWT) is a potential alternative to optimize the measurement of this outcome. Objectives To assess the t validity of the 2MWT for assessing exercise capacity in individuals with PD. Methods A methodological study was developed. People with idiopathic PD, age ≥ 50 years, medically stable for at least 6 months, classified between the stages 1-3 of the modified Hoehn and Yahr scale were included. Individuals were instructed to walk the longest possible distance in six minutes in a 30-meter corridor. Standardized stimuli were provided every minute of the test. In the second and sixth minutes, the distances covered were recorded. Two tests were performed with an interval of 30 minutes or until hemodynamic stabilization. The best total distance covered (in meters) was used in the analyses. Descriptive statistics was used to characterize the sample. Pearson's Correlation Coefficient was used to investigate the correlation between the tests (6MWT and 2MWT). Regression analysis was used to develop an equation to predict the distance covered in the 6MWT based on the 2MWT. The intraclass correlation coefficient (ICC) was used to assess the validity of the equation. The magnitude of the correlation was classified as follows: very low≤ 0.25; low=0.26-0.49; moderate=0.50-0.69; high = 0.70-0.89; and very high = 0.90-1.00. The significance level was α=0.05. Results Forty-six individuals, 32 males (69.6%), mean age 66.93±8.34 years, and mean disease duration 8.5±5.96 years were included. Most were classified at stage 2.0 (54 .3%) and 3.0 (17.4%) on the modified Hoehn & Yahr Scale. Significant, and very high magnitude correlation between the distance covered in the tests was found (6MWT and 2MWT) (r=0.95; p < 0.001). The equation developed to estimate the distance covered in the 6MWT explained 91% of the 6MWT variability: 6MWTdistance=46,31+(2,40x2MWTdistance). Significant, and very high magnitude agreement between the distance covered in the 6MWT and predicted by the equation was found (ICC= 0.90; p < 0.001). Conclusion Preliminary results indicate adequate validity of the 2MWT to assess exercise capacity in individuals with PD. Furthermore, the developed equation was adequate to predict the distance covered in the 6MWT based upon in the distance covered in the 2MWT. However, the study must be completed to ensure the results. Implications The 2MWT has potential to assess exercise capacity in individuals with PD, and the developed equation can estimate the distance covered in the 6MWT. This can optimize the measurement of this result, making the measurement feasible.

VALIDITY OF THE 2-MINUTE WALK TEST TO ASSESS EXERCISE CAPACITY IN INDIVIDUALS WITH PARKINSON DISEASE

Characterization of Walking in Mild Parkinson's Disease: Reliability, Validity and Discriminant Ability of the Six-Minute Walk Test Instrumented with a Single Inertial Sensor

Psychometric properties of 3-meter backward walk test (3MBWT) in people with Parkinson disease

Test-retest Reliability and Minimum Detectable Change of 2-Minute Walk Test among Individuals with Knee Osteoarthritis

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis

The 2-Minutes Walking Test Is Not Correlated with Aerobic Fitness Indices but with the 5-Times Sit-to-Stand Test Performance in Apparently Healthy Older Adults

Prediction of Poor Short-Term Prognosis and Unmet Needs in Advanced Chronic Obstructive Pulmonary Disease: Use of the Two-Minute Walking Distance Extracted from a Six-Minute Walk Test

Validity and reliability of the Six-Minute Pegboard Ring Test for assessing functional capacity and upper limb function in persons with multiple sclerosis

Usefulness of the 6-minute walk test vs cardiopulmonary exercise test for exercise prescription in coronary artery disease patients going into a phase III cardiac rehabilitation program

Validity and reliability of automated treadmill six-minute walk test in patients entering exercise-based cardiac rehabilitation

A moderate 200-m walk test estimates peak oxygen uptake in elderly outpatients with cardiovascular disease

Validation of the two-minute step test in obese with comorbibities and morbidly obese patients

Between-Day Reliability of the Gait Characteristics and Their Changes During the 6-Minute Walking Test in People With Multiple Sclerosis

Measuring Physical Functioning Using Wearable Sensors in Parkinson Disease and Chronic Obstructive Pulmonary Disease (the Accuracy of Digital Assessment of Performance Trial Study): Protocol for a Prospective Observational Study

The Senior Fitness Test as a functional measure in Parkinson's disease: a pilot study

Senior Fitness Test in the assessment of the physical fitness of people with Parkinson's disease

Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson's disease

Comparison between standard 6 minutes field walk test and walking pad for functional evaluation in patients with chronic lung disease

Self-Administered Six-Minute Walk Test Using a Free Smartphone App in Asymptomatic Adults: Reliability and Reproducibility

Reproducibility of three six-minute walk tests in COPD patients referred for pulmonary rehabilitation

Is the six-minute walk test still reliable compared to cardiopulmonary exercise test for exercise capacity in children with congenital heart disease?